Reduction of the concentrations of prostaglandins E2 and F2α, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate

Toxicology Letters

Volumn 85, Issue 3, 1996, Pages 143-149

  Leunga, Lai K ^a   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Ciprofibrate; Eicosanoids; Hepatocytes; Peroxisome

Indexed keywords

CIPROFIBRATE; ICOSANOID; PEROXISOME PROLIFERATOR; PROSTAGLANDIN E2; THROMBOXANE B2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; RAT;

ACYL-COA OXIDASE; ANALYSIS OF VARIANCE; ANIMALS; ANTILIPEMIC AGENTS; CELL DIVISION; CELLS, CULTURED; CLOFIBRIC ACID; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; MALE; MICROBODIES; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2;

EID: 0029967121     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4274(96)03639-9     Document Type: Article

References (36)

1. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 12, 1-58.
2. Conway, J.G., Cattley, R.C., Popp, J.A. and Butterworth, B.E. (1989) Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate. Drug Metab. Rev. 21, 65-102.
3. Keppler, D. (1994) Leukotrienes and other eicosanoids in liver pathophysiology. In: I.M. Arias, J.L. Boyer, N. Fausto, W.B. Jakoby, D.A. Schachter and D.A. Shafritz (Eds.), The Liver: Biology and Patholobiology, Third Edition, Raven Press, New York, pp. 1015-1029.
4. 2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochim. Biophys. Acta 959, 143-152.
5. Garrity, M.J., Brass, E.P. and Robertson, R.P. (1984) Kinetics of prostaglandin E metabolism in isolated hepatocytes. Biochim. Biophys. Acta 796, 136-141.
6. 2alpha in primary cultures of rat hepatocytes. Biochim. Biophys. Acta 879, 330-338.
7. 2alpha. J. Lipid Res. 31, 1477-1482.
8. Wilson, M.W., Lay, L.T., Chow, C.K., Tai, H.H., Robertson, L.W. and Glauert, H.P. (1995) Altered hepatic eicosanoid concentrations in rat treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Arch. Toxicol. 69, 491-497.
9. Kuiper, J., Casteleyn, E. and Van Berkel, T.J.C. (1988) Regulation of liver metabolism by intercellular communication. Adv. Enzyme Regul. 27, 193-208.
10. Häussinger, D. (1989) Regulation of hepatic metabolism by extracellular nucleotides and eicosanoids. The role of cell heterogeneity. J. Hepatol. 8, 259-266.
11. Turner, N.A., Wilson, N.M., Jefcoate, C.R. and Pitot, H.C. (1988) The expression and metabolic activity of cytochrome P-450 isozymes in control and phenobarbital-induced primary cultures of rat hepatocytes. Arch. Biochem. Biophys. 263, 204-215.
12. Seglen, P.O. (1976) Preparation of isolated rat liver cells. Methods Cell Biol. 13, 29-83.
13. Poosch, M.S. and Yamazaki, R.K. (1986) Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta 884, 585-593.
14. Gill, J.L. (1978) Design and Analysis of Experiments in the Animal and Medical Sciences. Volume 1. The Iowa State University Press, Ames, Iowa.
15. 2 in the liver of rats fed a choline deficient diet: possible involvement in liver tumor promotion. Cancer Lett. 46, 129-135.
16. 2alpha, glutathione-S-transferase activity, and oxidative stress. Prostaglandins Leukotrienes Essential Fatty Acids 42, 45-50.
17. Leung, L.K. and Glauert, H.P. (1996) Role of hepatic prostaglandins in the induction of DNA synthesis by phenobarbital and the peroxisome proliferator ciprofibrate in rats. Fund. Appl. Toxicol. 30, 132.
18. Denda, A., Tang, Q., Endoh, T., Tsujiuchi, T., Horiguchi, K., Noguchi, O., Mizumoto, Y., Nakae, D. and Konishi, Y. (1994) Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis 15, 1279-1283.
19. Tang, Q., Denda, A., Tsujiuchi, T., Tsutsumi, M., Amanuma, T., Murata, Y., Maruyama, H. and Konishi, Y. (1993) Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn. J. Cancer Res. 84, 120-127.
20. Denda, A., Ura, H., Tsujiuchi, T., Tsutsumi, M., Eimoto, H., Takashima, Y., Kitazawa, S., Kinugasa, T. and Konishi, Y. (1989) Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis 10, 1929-1935.
21. Cattley, R.C. and Popp, J.A. (1989) Differences between the promoting activities of the peroxisome proliferator Wy-14 643 and phenobarbital in rat liver. Cancer Res. 49, 3246-3251.
22. Borges, T., Peterson, R.E., Pitot, H.C., Robertson, L.W. and Glauert, H.P. (1993) Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of 2-stage hepatocarcinogenesis in rats. Cancer Lett. 72, 111-120.
23. Glauert, H.P. (1991) Histochemical and stereological analysis of putative preneoplastic hepatic lesions. Prog. Histochem. Cytochem. 23, 84-90.
24. Marsman, D.S. and Popp, J.A. (1994) Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14 643. Carcinogenesis 15, 111-117.
25. Kraupp-Grasl, B., Huber, W., Putz, B., Gerbracht, U. and Schulte-Hermann, R. (1990) Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res. 50, 3701-3708.
26. Brass, E.P. and Ruff, L.J. (1991) Effect of clofibrate treatment on hepatic prostaglandin catabolism and action. J. Pharmacol. Exp. Ther. 257, 1034-1038.
27. Tran-Thi, T.A., Gyufko, K., Henninger, H., Busse, R. and Decker, K. (1987) Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture. J. Hepatol. 5, 322-331.
28. Johnston, D.E., Peterson, M.B., Mion, F., Berninger, R.W. and Jefferson, D.M. (1991) Synthesis and degradation of eicosanoids in primary rat hepatocyte cultures. Prostaglandins Leukotrienes Essential Fatty Acids 43, 119-132.
29. Mion, F., Jasuja, R. and Johnston, D.E. (1995) The contribution of hepatocytes to prostaglandin synthesis in rat liver. Prostaglandins Leukotrienes Essential Fatty Acids 53, 109-115.
30. Gronn, M., Christensen, E., Hagve, T.A. and Christophersen, B.O. (1992) Effects of clofibrate feeding on essential fatty acid desaturation and oxidation in isolated rat liver cells. Biochim. Biophys. Acta 1123, 170-176.
31. Quiroga, J. and Prieto, J. (1993) Liver cytoprotection by prostaglandins. Pharmacol. Ther. 58, 67-91.
32. Skouteris, G.G., Ord, M.G. and Stocken, L.A. (1988) Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J. Cell. Physiol. 135, 516-520.
33. 2 and rat liver regeneration. Gastroenterology 105, 495-499.
34. Okumura, T., Kanemaki, T. and Kitade, H. (1993) Stimulation of glucose incorporation into glycogen by E-series prostaglandins in cultured rat hepatocytes. Biochim. Biophys. Acta 1176, 137-142.
35. 2. Biochem. Biophys. Res. Commun. 137, 404-410.
36. Kunkel, S.L., Chensue, S.W. and Phan, S.H. (1986) Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol. 136, 186-192.